The burden of heart failure

Chronic heart failure (CHF) places a heavy burden not only on patients and their families but also on society, through enormous use of health care resources. CHF has an overall population prevalence of approximately 1–3%, rising to approximately 10% in the very elderly. Following a first hospital admission for heart failure, patients have a 5-year mortality of 75% — a survival rate worse than that for most forms of cancer. CHF impairs quality of life more than almost any other chronic medical problem. Hospital admissions for CHF have increased markedly over the past two decades. CHF accounts for about 5% of all medical admissions and approximately 2% of total health care expenditure. Despite improvements in medical management, under-treatment is common. Because of the increase in survival after acute myocardial infarction and ageing of the population, the number of patients with CHF will increase rapidly in most industrialized countries. CHF will still pose one of the greatest health care challenges of the 21 st century.

[1]  J. Remes,et al.  Incidence of heart failure in eastern Finland: a population-based surveillance study. , 1992, European heart journal.

[2]  H. S. Klopfenstein,et al.  Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study. , 1995, Circulation.

[3]  D. Levy,et al.  Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. , 1999, Journal of the American College of Cardiology.

[4]  M. Pfeffer,et al.  Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators. , 1999, Journal of cardiac failure.

[5]  D. Levy,et al.  The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.

[6]  J. McMurray,et al.  Changes in notions about heart failure , 2001, The Lancet.

[7]  J. Mcmurray Heart failure: we need more trials in typical patients. , 2000, European heart journal.

[8]  S Capewell,et al.  Heart failure and the aging population: an increasing burden in the 21st century? , 2003, Heart.

[9]  E. Antman,et al.  ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .

[10]  Cohen-Solal Alain,et al.  Practical recommendations for the use of ACE inhibitors, beta‐blockers and spironolactone in heart failure: putting guidelines into practice , 2001 .

[11]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[12]  R. Klein,et al.  The Beaver Dam Health Outcomes study , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[13]  T. Kahan,et al.  Epidemiology of heart failure in Sweden — a national survey , 2001, European journal of heart failure.

[14]  S Capewell,et al.  More ‘malignant’ than cancer? Five‐year survival following a first admission for heart failure , 2001, European journal of heart failure.

[15]  Simon Stewart,et al.  Effects of a multidisciplinary, home-based intervention on planned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study , 1999, The Lancet.

[16]  B. Howard,et al.  A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: the Strong Heart Study. , 2001, American heart journal.

[17]  I. Ringqvist,et al.  Left ventricular systolic dysfunction in 75-year-old men and women; a population-based study. , 2001, European heart journal.

[18]  J. Gardin,et al.  Importance of heart failure with preserved systolic function in patients ≥65 years of age , 2001 .

[19]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[20]  M. Bristow,et al.  Economic impact of heart failure in the United States: time for a different approach. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[21]  L. Stevenson,et al.  Preferences for quality of life or survival expressed by patients with heart failure. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[22]  S G Thompson,et al.  Incidence and aetiology of heart failure; a population-based study. , 1999, European heart journal.

[23]  Simon Stewart,et al.  Epidemiology, aetiology, and prognosis of heart failure , 2000, Heart.

[24]  K. Swedberg,et al.  Guidelines for the diagnosis and treatment of chronic heart failure. , 2001, European heart journal.

[25]  R W Koster,et al.  Increase in hospital admission rates for heart failure in The Netherlands, 1980-1993. , 1996, Heart.

[26]  K. Bailey,et al.  Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. , 1998, Circulation.

[27]  William H. Rogers,et al.  Functional Status and Well-Being of Patients with Chronic Conditions , 1989 .

[28]  R. Lancashire,et al.  Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study , 2001, The Lancet.

[29]  J. McMurray Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors? , 1998, European heart journal.

[30]  A Hofman,et al.  Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. , 1999, European heart journal.

[31]  J. McMurray,et al.  Randomised controlled trial of specialist nurse intervention in heart failure , 2001, BMJ : British Medical Journal.

[32]  Hugh Tunstall-Pedoe,et al.  Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population , 1997, The Lancet.

[33]  Heribert Schunkert,et al.  Left-ventricular dysfunction , 1998, The Lancet.

[34]  E. Segovia,et al.  Prevalence of heart failure in Asturias (a region in the north of Spain). , 2001, The American journal of cardiology.

[35]  J. Pell,et al.  Evidence of Improving Prognosis in Heart Failure: Trends in Case Fatality in 66 547 Patients Hospitalized Between 1986 and 1995 , 2000, Circulation.

[36]  J. McMurray,et al.  Failing ageing hearts. , 2001, European heart journal.

[37]  D. Mant,et al.  Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey , 1999, BMJ.

[38]  D. Grobbee,et al.  Angiotensin converting enzyme inhibition and hospitalisation rates for heart failure in the Netherlands, 1980 to 1999: the end of an epidemic? , 2002, Heart.

[39]  J. Croft,et al.  Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. , 1999, American heart journal.

[40]  L Wilhelmsen,et al.  Risk factors for heart failure in the general population: the study of men born in 1913. , 1989, European heart journal.

[41]  A. Stewart,et al.  Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. , 1989, JAMA.

[42]  J. McMurray,et al.  Trends in hospitalization for heart failure in Scotland 1980-1990. , 1993, European heart journal.

[43]  J. Hampton,et al.  How common is heart failure? Evidence from PACT (prescribing analysis and cost) data in Nottingham. , 1995, Journal of public health medicine.

[44]  Bertram Pitt,et al.  Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) , 1997, The Lancet.

[45]  Heart failure and the ageing population: An increasing burden in the 21st century? , 2003 .

[46]  G. Bonsel,et al.  Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. , 1994, American journal of public health.

[47]  J. McMurray,et al.  Clinical epidemiology of heart failure: public and private health burden. , 1998, European heart journal.

[48]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[49]  E. J. Brown,et al.  The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[50]  P E Leaverton,et al.  Prevalence and mortality rate of congestive heart failure in the United States. , 1992, Journal of the American College of Cardiology.

[51]  J. McMurray,et al.  Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak? , 2001, European heart journal.

[52]  J. Hilden,et al.  Cross sectional study estimating prevalence of heart failure and left ventricular systolic dysfunction in community patients at risk , 2001, Heart.

[53]  D. Kelly Paul Dudley White International Lecture. Our future society. A global challenge. , 1997, Circulation.

[54]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[55]  K. Bailey,et al.  The incidence and prevalence of congestive heart failure in Rochester, Minnesota. , 1993, Mayo Clinic proceedings.

[56]  J. Heikkilä,et al.  Congestive heart failure in old age: prevalence, mechanisms and 4‐year prognosis in the Helsinki Ageing Study , 1997, Journal of internal medicine.